Close Menu

NEW YORK (GenomeWeb) – Trovagene announced today that it has signed an in-network provider agreement with Blue Cross Blue Shield of Illinois, establishing access for plan members to the company's full line of Trovera liquid biopsy tests.

This product line currently includes assays performed on either blood or urine, which detect mutations in EGFR, KRAS, and BRAF.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A Minnesota toddler given a gene therapy to treat her spinal muscular atrophy is now walking, according to Newsweek.

NBC Bay Area reports a California lab has been certified to conduct forensic mitochondrial DNA sequencing.

The New York Times reports on how environmental DNA sampling could monitor endangered species.

In Cell this week: proteomic, genomic, and transcriptomic analysis of endometrial cancer; deep neural network learning-based approach to antibiotic discovery; and more.